Call for abstracts deadline June 3: Academic symposium with Harvard Law School's Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics, Oct. 20
FDLI SmartBrief | Jun 02, 2014
Are you currently an academic interested in the topic of "Emerging Issues and New Frontiers for FDA Regulation"? If so, submit your one-page abstract on a wide range of topics, including stem cell therapies, nanotechnologies, genetic (and biomarker) tests, gene therapies, personalized medicine, comparative efficacy research, drug-resistant pathogens, globalized markets, tobacco, GMOs, bioterrorism countermeasures, mobile health technologies, health IT, drug shortages and other related topics. Selected participants will present at the Oct. 20 symposium and will be expected to submit a completed article by Dec. 15 to be considered for publication in a 2015 issue of FDLI's Food and Drug Law Journal (FDLJ). Publication decisions will be made based on usual FDLJ standards. Please submit your abstract by Tuesday, June 3, to Davina Rosen Marano at dsr@fdli.org.
No comments:
Post a Comment